Every Form 4 that Texas Community Bancshares, Inc. (TCBS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TCBS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TCBS filings page.
Texas Community Bancshares, Inc. director Anthony Scavuzzo reported an open-market purchase of Common Stock. On June 10, 2026, he bought 20,000 shares at $17.25 per share, bringing his directly held Common Stock position to 106,065 shares.
He also holds stock options on 8,144 shares of Common Stock with a $16.00 exercise price expiring on August 31, 2032. Footnotes state that both restricted stock and these options vest at a rate of 20% per year commencing on August 31, 2023.
Texas Community Bancshares, Inc. President and CEO Jason Sobel reported an open-market sale of 2,100 shares of common stock at $17.2505 per share. After this sale, he directly holds 18,190 common shares, along with additional indirect holdings through an ESOP and an IRA.
He also holds stock options on 58,639 shares of common stock with a $13.75 exercise price, expiring in 2033, which vest at a rate of 20% per year starting on February 28, 2024. Some directly held shares include restricted stock that vests on the same schedule.
Texas Community Bancshares, Inc. senior executive Haskell Strange reported an open-market sale of company stock. As SVP and COO, he sold 1,765 shares of common stock at an average price of $17.2511 per share in a direct transaction.
After the sale, Strange directly holds 4,819 common shares, some of which are restricted stock that vest 20% per year starting on February 28, 2024. He also has indirect holdings of 6,066 shares through a 401(k) plan and 4,527 shares through an ESOP.
In addition, Strange holds stock options covering 24,433 shares of common stock with an exercise price of $15.67 per share, expiring on February 28, 2033. These options vest 20% per year beginning on February 28, 2024, indicating a continuing equity-based compensation position alongside this sale.